LONGBOARD PHARMACEUTICALS IN

CUSIP: 54300N103 Class: Common Stock

Cormorant Asset Management, LP's Holding History (CIK: 0001583977)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 2,790,462 Value ($000) $93,006 Avg Close — Range —
Q2 2024
Shares 2,790,462 Value ($000) $75,426 Avg Close — Range —
Q1 2024
Shares 3,353,141 Value ($000) $72,428 Avg Close — Range —
Q4 2023
Shares 2,353,141 Value ($000) $14,189 Avg Close — Range —
Q3 2023
Shares 2,353,141 Value ($000) $13,083 Avg Close — Range —
Q2 2023
Shares 2,353,141 Value ($000) $17,272 Avg Close — Range —
Q1 2023
Shares 2,353,141 Value ($000) $9 Avg Close — Range —
Q4 2022
Shares 2,118,283 Value ($000) $7 Avg Close — Range —
Q3 2022
Shares 2,118,283 Value ($000) $7,880 Avg Close — Range —
Q2 2022
Shares 2,273,221 Value ($000) $7,024 Avg Close — Range —
Q1 2022
Shares 2,273,221 Value ($000) $12,139 Avg Close — Range —
Q4 2021
Shares 2,273,221 Value ($000) $11,069 Avg Close — Range —
Q3 2021
Shares 2,273,221 Value ($000) $20,155 Avg Close — Range —
Q2 2021
Shares 2,321,403 Value ($000) $20,869 Avg Close — Range —
Q1 2021
Shares 2,356,000 Value ($000) $37,193 Avg Close — Range —